Recruiting

Observational Study

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Code:

NCT01709448

Conditions

Neoplasms, Squamous Cell

Papillomavirus Infections

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of this study is to determine whether a model can be created to predict the progression of early anal cancer precursor lesions in HIV using potential predictors such as: HIV treatment history, smoking history, sexual history, human papillomavirus viral load, human papillomavirus protein expression, and cell markers associated with progression of HPV-related lesions.

Conditions

Neoplasms, Squamous Cell

Papillomavirus Infections

Study ID

NCT01709448

Start date

Jan, 2009

Status verified date

Oct, 2012

Completion date

Mar, 2014

Anticipated

Primary completion date

Mar, 2014

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • HIV-infected
  • Age > 18 years old
  • Abnormal anal screening cytology

Exclusion Criteria:

  • Inability to sign informed consent
  • Life-threatening illness or other contraindication for high-resolution anoscopy
  • anal intraepithelial neoplasia not confirmed by anal biopsy
  • history of anal carcinoma
  • history of HPV vaccination

Study Design

Enrollment

165 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • histological diagnosis of high-grade squamous intra-epithelial lesion confirmed by anal biopsy [ Time Frame: 12 months, 24 months, 36 months ]

Central Contacts and Locations

Central contacts

Locations

Cincinnati VA Medical Center

Recruiting

Cincinnati, Ohio, United States, 45225

Contacts

University of Cincinnati

Recruiting

Cincinnati, Ohio, United States, 45267

Contacts

Principal Investigator:

Jaime C Robertson, MD

More Information

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Last update posted

Oct 18, 2012

Last verified

Oct, 2012

Keywords

  • Neoplasms, Squamous Cell
  • Papillomavirus Infections
  • HIV

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Institute of Allergy and Infectious Diseases (NIAID) on 2012-10-18.